Morningstar

Agilent Technologies Inc A

Morningstar Rating
Unlock
Stock XNYS Rating as of
$131.46 −4.64 (3.41%)
View Full Chart
As of Delayed Price Closed

Company Report

View Archive

Agilent's Wide Moat Appears Intact in Its Life Science, Diagnostic, and Applied End Markets

Julie Utterback

Agilent provides tools to analyze the structural properties of various chemicals, molecules, and cells. The company is one of the leading providers of chromatography and mass spectrometry tools, which have applications in a variety of end markets, including the healthcare, chemical, food, and environmental fields. While healthcare-related applications, including clinical diagnostics, remain Agilent’s largest end market, Agilent generates about half of its sales from nonhealthcare fields, too.

Read Full Report

Price vs Fair Value

View History
A is trading within a range we consider fairly valued.
Price
$131.46
Fair Value
LOCK|@G
Uncertainty
LOCK|sssQ
1-Star Price
LOCK|x.?z%
5-Star Price
LOCK|@.jM
Economic Moat
LOCK|&k
Capital Allocation
LOCK|Y?%<P>w

Bulls Say, Bears Say

Bulls

Agilent's innovation engine and cost control efforts have been on display through strong growth and margin expansion since spinning out its electronic measurement business Keysight in November 2014.

Bears

Due to its dependence on one-time sales and its exposure to some cyclical end markets, Agilent's financial results may weaken during uncertain times.

Show More

Articles & Videos

Trading Information

Previous Close Price
$136.10
Day Range
$130.94–135.80
52-Week Range
$108.35–160.27
Bid/Ask
$129.54 / $133.50
Shares Outstanding
282.43M
Market Cap
$37.13B
Volume/Avg
4M / 2M

Key Statistics

Price/Earnings (Normalized)
22.63
Price/Sales
5.16
Dividend Yield (Trailing)
0.77%
Dividend Yield (Forward)
0.78%
Total Yield
1.81%

Company Profile

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Mid Core
Total Number of Employees
18,100
Website
https://www.agilent.com

Competitors

Valuation

View More
Metric
A
TMO
WAT
Price/Earnings (Normalized)
 22.6322.9927.17
Price/Book Value
 5.213.812.37
Price/Sales
 5.164.446.39
Price/Cash Flow
 20.2920.5825.29
Price/Earnings
A
TMO
WAT

Financial Strength

Metric
A
TMO
WAT
Quick Ratio
 1.460.970.97
Current Ratio
 2.101.531.79
Interest Coverage
 15.475.355.87
Quick Ratio
A
TMO
WAT

Profitability

Metric
A
TMO
WAT
Return on Assets (Normalized)
 13.11%8.27%9.95%
Return on Equity (Normalized)
 24.81%17.01%17.93%
Return on Invested Capital (Normalized)
 16.82%10.28%13.11%
Return on Assets
A
TMO
WAT

Diagnostics & Research Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
LOCK|qD@^K^KPLOCK|?q$198B
 Danaher Corp
DHR
LOCK|<KM%>L#cLOCK|KL&$144B
 IDEXX Laboratories Inc
IDXX
LOCK|GT>&BgwSLOCK|@CF$45B
 Waters Corp
WAT
LOCK|xQhxpLZLOCK|<#$$36B
 IQVIA Holdings Inc
IQV
LOCK|@F$^g&sLOCK|^<km^$34B
 Illumina Inc
ILMN
LOCK|zz^SHbLOCK|pmz^!$28B
 Mettler-Toledo International Inc
MTD
LOCK|Zqt@>zV!LOCK|q#c!#$26B
 Quest Diagnostics Inc
DGX
LOCK|PX&?l&#LOCK|Fhx@$23B
 Labcorp Holdings Inc
LH
LOCK|dj#RrT^LOCK|fcB$$$23B

Sponsor Center